Judith M. Matthews
CIK: 0001734033
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ETON
Eton Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
About Matthews Judith M.
Matthews Judith M. (SEC CIK 0001734033) files insider reports with the SEC as Chief Financial Officer of Eton Pharmaceuticals, Inc. (ETON).
Signal8 holds 2 ownership filings by Matthews Judith M. (1 Form 3, 1 Form 4), filed between Jun 1, 2026 and Aug 4, 2026. Those filings report 1 transaction, the latest on Jul 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Matthews Judith M.'s filings is in DEERPARK, IL.
Recent filings by Matthews Judith M.
- Jul 31, 2026: Grant or award of ETON derivative securities (Form 4, code A).
Other insiders filing for Eton Pharmaceuticals, Inc. (ETON)
- Krempa David, Chief Business Officer
- MAIER PAUL V, Director
- BRYNJELSEN SEAN, President & CEO
- Radosavljevic Danka, Chief Operating Officer
- CASAMENTO CHARLES J, Director
- Erdogan-Trinkaus Ipek, Chief Commercial Officer